full
border
#666666
http://www.lennonsearch.com/wp-content/themes/smartbox-installable/
https://www.lennonsearch.com/
#26ADE4
style3
Over 25 Years Of Expertise
828-403-6096

Archive for May, 2014

29
May

Armed with ex-Merck immunotherapy and some promising preclinical data, startup ARMO BioSciences has pulled in $30 million in venture cash to study whether its candidate can help kill cancer cells by galvanizing an immune system response. …read more Source: ARMO pockets $30M for its immunotherapy ahead of the ASCO spotlight     

29
May

Johnson & Johnson’s busy deal team in California has nailed down another development pact–this time zeroing in on new technology at a Berkeley biotech that will be used to expand its considerable efforts on prostate cancer R&D. …read more Source: J&J expands prostate cancer program with cancer vax tech from Aduro     

28
May

Array BioPharma has watched its shares fall steadily earthward since ex-partner Amgen backed out of a diabetes deal last summer, but a new deal with Big Biotech Biogen Idec sent the company up about 5% on renewed hopes for its early-stage R&D efforts. …read more Source: Slumping Array aligns with Biogen on early autoimmune R&D […]

default
Loading posts...
link_magnifier
#5C5C5C
off
fadeInDown
loading
#5C5C5C
off